These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment. Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ J Affect Disord; 1984 Dec; 7(3-4):265-72. PubMed ID: 6151957 [TBL] [Abstract][Full Text] [Related]
26. Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy. Amsterdam JD; Rybakowski J; Gottlieb J; Frazer A J Affect Disord; 1988; 14(1):75-81. PubMed ID: 2828448 [TBL] [Abstract][Full Text] [Related]
27. Platelet accumulation of histamine in depression. Wood K; Harwood J; Coppen A Lancet; 1983 Aug; 2(8348):519-20. PubMed ID: 6136680 [No Abstract] [Full Text] [Related]
28. 3H-imipramine binding to previously frozen platelet membranes from depressed patients, before and after treatment. Healy D; Theodorou AE; Whitehouse AM; Lawrence KM; White W; Wilton-Cox H; Kerry SM; Horton RW; Paykel ES Br J Psychiatry; 1990 Aug; 157():208-15. PubMed ID: 2224370 [TBL] [Abstract][Full Text] [Related]
29. Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? Steardo L; Barone P; Monteleone P; Iovino M; Cardone G Acta Psychiatr Scand; 1987 Aug; 76(2):129-33. PubMed ID: 2890265 [TBL] [Abstract][Full Text] [Related]
30. Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors. Lu RB; Ho SL; Ho BT; Leu SY; Shian LR; Chen WL J Affect Disord; 1986; 10(3):177-84. PubMed ID: 2943770 [TBL] [Abstract][Full Text] [Related]
31. [3H]yohimbine binding to platelet alpha 2-adrenoceptors in depression. Katona CL; Theodorou AE; Davies SL; Hale AS; Kerry SM; Horton RW; Kelly JS; Paykel ES J Affect Disord; 1989; 17(3):219-28. PubMed ID: 2551946 [TBL] [Abstract][Full Text] [Related]
32. Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls. Tan CH; Javors MA; Seleshi E; Lowrimore PA; Bowden CL Life Sci; 1990; 46(16):1175-80. PubMed ID: 2342403 [TBL] [Abstract][Full Text] [Related]
33. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Alevizos B; Alevizos E; Leonardou A; Zervas I Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912 [TBL] [Abstract][Full Text] [Related]